0.3675
0.0234 (6.8%)
0.0234 (6.8%)
Upgrade to Real-Time
Afterhours (Closed)
Volume | 420,845 |
|
|||||
News | - | ||||||
Day High | 0.36 | Low High |
|||||
Day Low | 0.33 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Check Cap Ltd | CHEK | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.34 | 0.33 | 0.36 | 0.36 | 0.3441 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
719 | 420,845 | $ 0.3471136 | $ 146,081 | - | 0.29 - 1.31 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:49:41 | formt | 200 | $ 0.3675 | USD |
Check Cap Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 16.99M | 46.23M | 116.27M | $ - | $ - | -0.21 | -1.50 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | - | - | - |
Check Cap News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CHEK Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.34 | 0.36 | 0.3101 | 0.3359711 | 342,601 | 0.0275 | 8.09% |
1 Month | 0.32 | 0.381 | 0.29 | 0.3349043 | 414,422 | 0.0475 | 14.84% |
3 Months | 0.36 | 0.40 | 0.29 | 0.3366679 | 450,786 | 0.0075 | 2.08% |
6 Months | 0.59 | 0.64 | 0.29 | 0.3805246 | 749,380 | -0.2225 | -37.71% |
1 Year | 1.10 | 1.31 | 0.29 | 0.6968912 | 1,022,665 | -0.7325 | -66.59% |
3 Years | 2.01 | 4.49 | 0.243 | 1.51 | 3,592,398 | -1.64 | -81.72% |
5 Years | 20.40 | 24.00 | 0.243 | 1.75 | 2,277,418 | -20.03 | -98.2% |
Check Cap Description
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. |